arrow
S

Scott F. Huntington

Yale University
H指数:28
被引数:2,940

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma

外周CD8<sup>+</sup> T细胞克隆性和NK细胞扩增标志着惰性B细胞淋巴瘤对 mosunetuzumab 的早期反应

2026-09-120
OA
Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2026 Featured Updates to the NCCN Guidelines

NCCN Guidelines® 要点:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,版本 2.2026

2026-03-013
PRE
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML

异基因造血干细胞移植在治疗中期风险急性髓系白血病中的成本效益:即刻移植与延迟移植的比较

2025-08-060
OAAI
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers
2024-11-141
OAAI
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort
2023-10-314
OAAI
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study
2023-03-075
PRE